Outer membrane vesicles and uses thereof
US8029807B2 · kind B2 · utility
11Cited by
0References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 3, 2009 |
| Grant date | Oct 4, 2011 |
| Priority date | — |
| Expiry date | Nov 3, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a Gram negative bacterium in which the expression of a protein involved in LPS transport to the outer membrane is functionally downregulated such that the level of LPS in the outer membrane is decreased compared to a wild-type Gram negative bacterium. Down regulation of Imp and MsbA proteins can result in such a bacterium. Outer membrane vesicle preparations derived from the Gram negative bacterium of the invention can be used in vaccines to provide protection against bacterial infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.